Blue Owl Capital Inc (OWL)

Blue Owl Capital Inc. operates as an alternative asset manager in the United States. It offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. The company also provides private financing solutions, such as direct lending products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; alternative credit; investment grade credit; liquid credit; and other credit solutions. In addition, the company offers GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants, as well as real estate debt finance through net lease and real estate credit. It offers its solutions through permanent capital vehicles and long-dated private funds. Blue Owl Capital Inc. is headquartered in New York, New York.

• 年次報告書（10-K）

  事業内容、財務実績、リスクをまとめた年次の概要。

  提出日: 2026-02-19

  書類を見る

• 四半期報告書（10-Q）

  直近3か月間の業績に関する最新情報。

  提出日: 2026-07-31

  書類を見る

• 臨時報告書（8-K）

  経営陣の交代や重要な発表など、大きな出来事に関するお知らせ。

  提出日: 2026-08-18

  書類を見る

• 3d agoNEGATIVE
  Il titolo Blue Owl è sceso dal massimo di agosto di $12.7 agli attuali $9.32.

  Blue Owl Capital Inc. (OWL) has seen its stock price decline to $9.32, marking a 27.6% drop from its August high of $12.7. This downturn occurred despite easing concerns within the private credit sector. The company, along with peers like Ares, BlackRock, Blackstone, and Apollo, experienced weaker redemption requests in the second quarter. Investors are observing this trend closely as it impacts the valuation of private credit firms, even as broader sector fears subside.

• 27d agoPOSITIVE
  Blue Owl: possibile short squeeze dopo il golden cross nel turnaround

  Blue Owl Capital Inc. (OWL) shares have experienced a significant recovery, climbing from a low of $7.60 in April to approximately $11.85. Technical indicators suggest further upside potential, highlighted by a recent 'golden cross' formation on August 14th, where the 50-day and 200-day weighted moving averages intersected. This bullish signal, combined with a rising flag pattern and easing concerns in the AI sector, could fuel additional gains. Investors are watching for a potential short squeeze, supported by these positive technical and market sentiment shifts.

• 8/11/2026NEUTRAL
  Blue Owl Sets $500 Million Bond Sale to Pay Down Credit Lines

  Blue Owl Capital Inc. is reportedly planning a $500 million bond sale. This move follows issuance of notes by three of the firm's private credit funds earlier this year. The proceeds from the bond sale are intended to repay existing credit lines. While the bond sale itself is a financing activity, its impact on the equity value of Blue Owl Capital is neutral, as it primarily addresses debt management rather than signaling operational growth or decline.

• 8/5/2026POSITIVE
  Blue Owl BDCs Buy Back $90 Million of Shares to Support Value

  Blue Owl Capital Inc. announced that two of its private credit funds have repurchased a combined $90 million of shares. This marks the second consecutive quarter of share buybacks by these funds, signaling management's commitment to bolstering the vehicles' valuation. The move comes amid broader sector-wide turbulence, suggesting Blue Owl's confidence in its underlying assets and strategy. For investors, these repurchases can indicate a belief that the shares are undervalued, potentially leading to a stabilization or increase in asset value.

• 7/8/2026POSITIVE
  Blue Owl Buys £1.3 Billion UK Private Hospital Portfolio

  Blue Owl Capital Inc has successfully acquired a substantial portfolio of UK private hospitals valued at £1.3 billion. The transaction was completed with Malaysia's Employees Provident Fund, marking a significant expansion for Blue Owl in the UK healthcare real estate sector. This strategic acquisition is expected to bolster Blue Owl's alternative asset management offerings and potentially enhance its revenue streams through the operation and further development of these healthcare facilities. Investors may view this as a positive move, indicating strong growth potential and strategic foresight in a resilient market.

• 7/2/2026NEGATIVE
  Blue Owl Imposes Redemption Caps Again

  Blue Owl Capital's private credit funds are facing significant redemption requests for the second consecutive quarter, prompting the manager to impose withdrawal caps. This action indicates potential liquidity strains or investor concerns about the underlying assets within these funds. For investors, this raises questions about the stability and accessibility of capital within Blue Owl's private credit offerings, potentially impacting future fundraising and investor sentiment.

• 6/8/2026NEGATIVE
  Blue Owl Fund Hit by Redemptions Set to Sell $500 Million Bond

  Blue Owl Capital Inc.'s private credit fund, which previously capped redemptions, is now planning to sell $500 million in investment-grade bonds. This move signals potential liquidity strain within the fund, as it seeks to meet redemption requests by issuing new debt. Investors in Blue Owl's funds may face increased risk due to the fund's reliance on debt issuance to manage outflows, potentially impacting future returns and the overall stability of the fund's portfolio.